Undersøgelsen af patienter i kemoterapi viste, at Retacrit også var effektivt, når det blev givet ved indsprøjtning under huden, og at det gav de samme forbedringer i hæmoglobinniveauet som dem, der er beskrevet i den videnskabelige litteratur for andre epoetiner.
The study in patients receiving chemotherapy showed that Retacrit was also effective when it was injected subcutaneously, with similar improvements in haemoglobin levels as those reported in the scientific literature for other epoetins.